Algernon Pharmaceuticals Inc. (AGNPF)
USD 0.04
(0.0%)
USD 0.04
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -2.55 Million | -2.91 Million | -7.82 Million | -6.6 Million | -1.78 Million | -616.5 Thousand |
| Net Income | -6.78 Million | -6.05 Million | -7.73 Million | -8.53 Million | -1.89 Million | -937.59 Thousand |
| Depreciation & Amortization | 50.39 Thousand | 34.93 Thousand | - | - | 26.99 Thousand | 40.95 Thousand |
| Deferred income taxes | 1.61 Million | - | - | - | - | - |
| Stock-based compensation | 1.25 Million | 530.83 Thousand | 827.4 Thousand | 3.17 Million | - | 235.09 Thousand |
| Change in working capital | 1.26 Million | 2.58 Million | -597.87 Thousand | -1.06 Million | 93.95 Thousand | 43.62 Thousand |
| Other non-cash items | 40 Thousand | -8642.00 | -318.06 Thousand | -182.29 Thousand | -7617.00 | 1417.00 |
| Investing Cash Flow | -59.5 Thousand | -144.6 Thousand | -124.44 Thousand | -99.74 Thousand | 90.17 Thousand | - |
| Investments in PPE | -59.5 Thousand | -144.6 Thousand | -124.44 Thousand | -99.74 Thousand | -65.74 Thousand | - |
| Acquisitions | - | - | - | - | 100.6 Thousand | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -59.50 | -144.61 | -124.45 | -99.74 | 55.32 Thousand | - |
| Financing Cash Flow | 1.32 Million | 2.05 Million | 4.24 Million | 12.61 Million | 647.98 Thousand | 471.8 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -311.67 | - | - | - |
| Common Stock Issuance | 1.32 Million | 2.05 Million | 2.69 Million | 12.61 Million | 494.23 Thousand | 471.8 Thousand |
| Other Financing Activities | 1.32 Million | 2055.12 | 1.55 Million | 12.61 Million | 153.75 Thousand | 471.80 |
| Accounts receivables | 567.8 Thousand | 1.61 Million | -1.15 Million | -1.12 Million | 11.18 Thousand | -2038.00 |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 697.91 Thousand | 969.99 Thousand | 552.77 Thousand | 54.39 Thousand | 82.77 Thousand | 45.66 Thousand |
| Cash at beginning of period | 1.4 Million | 2.41 Million | 6.12 Million | 207.81 Thousand | 1.25 Million | 1.39 Million |
| Cash at end of period | 125.08 Thousand | 1.4 Million | 2.41 Million | 6.12 Million | 207.81 Thousand | 1.25 Million |
| Capital Expenditure | -59.5 Thousand | -144.6 Thousand | -124.44 Thousand | -99.74 Thousand | -65.74 Thousand | - |
| Effect of forex changes on cash | 175.00 | -428.00 | -8403.00 | 3538.00 | 818.00 | 3251.00 |
| Net cash flow / Change in cash | -1.28 Million | -1 Million | -3.71 Million | 5.91 Million | -1.04 Million | -141.45 Thousand |
| Free Cash Flow | -2.61 Million | -3.05 Million | -7.94 Million | -6.7 Million | -1.84 Million | -616.5 Thousand |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.44 Million | -1 Million | -521.55 Thousand | -6.78 Million | -2.52 Million | -1.12 Million |
| Depreciation & Amortization | 6085.00 | 7642.00 | 7428.00 | 50.39 Thousand | 13.33 Thousand | 12.83 Thousand |
| Deferred income taxes | - | - | - | 1.61 Million | - | - |
| Stock-based compensation | 61 Thousand | 156.61 Thousand | 69.03 Thousand | 1.25 Million | 69.79 Thousand | 194.1 Thousand |
| Change in working capital | -1.38 Million | 607.01 Thousand | 382.02 Thousand | 1.26 Million | 275.59 Thousand | 174.15 Thousand |
| Other non-cash items | -1.86 Million | 182.17 Thousand | 10.81 Thousand | 40 Thousand | 1.59 Million | 13.27 Thousand |
| Investing Cash Flow | 2.3 Million | -23.12 Thousand | - | -59.5 Thousand | -5581.00 | -27.01 Thousand |
| Investments in PPE | -29.61 Thousand | -23.12 Thousand | - | -59.5 Thousand | -5581.00 | -27.01 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 2.33 Million | -23.12 Thousand | - | -59.50 | -5.58 | -27.01 |
| Financing Cash Flow | 7500.00 | 265.57 Thousand | - | 1.32 Million | 269.16 Thousand | 973.99 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 7500.00 | 265.57 Thousand | - | 1.32 Million | 269.16 Thousand | 973.99 Thousand |
| Other Financing Activities | 7500.00 | 265.57 Thousand | - | 1.32 Million | 269.16 Thousand | 973.99 Thousand |
| Accounts receivables | 21.91 Thousand | -16.68 Thousand | 81.72 Thousand | 567.8 Thousand | -25.21 Thousand | 18.58 Thousand |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -1.4 Million | 623.7 Thousand | 300.3 Thousand | 697.91 Thousand | 300.8 Thousand | 155.57 Thousand |
| Cash at beginning of period | 76.27 Thousand | 74.16 Thousand | 125.08 Thousand | 1.4 Million | 434.23 Thousand | 220.58 Thousand |
| Cash at end of period | 609.52 Thousand | 76.27 Thousand | 74.16 Thousand | 125.08 Thousand | 125.08 Thousand | 434.23 Thousand |
| Capital Expenditure | -29.61 Thousand | -23.12 Thousand | - | -59.5 Thousand | -5581.00 | -27.01 Thousand |
| Effect of forex changes on cash | 4450.00 | -1297.00 | 1325.00 | 175.00 | -26.00 | -398.00 |
| Net cash flow / Change in cash | 533.24 Thousand | 2110.00 | -50.91 Thousand | -1.28 Million | -309.14 Thousand | 213.64 Thousand |
| Free Cash Flow | -1.81 Million | -262.16 Thousand | -52.24 Thousand | -2.61 Million | -578.28 Thousand | -759.95 Thousand |
WALL-B
SAI
SYNACT
RAMRAT
BSFFF
GEN